In the last decade, researchers have uncovered the molecular determinants of lung cancer and identified numerous nonoverlapping driver genomic events including epidermal growth factor receptor (EGFR), KRAS, ALK, ROS1, and HER2.5 Here, EGFR is linked to lung carcinoma.